查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553527

移植診斷的全球市場規模、佔有率和趨勢分析：按測試、產品、應用、移植部位、最終用途、地區和細分市場進行預測（2024-2030）

Transplant Diagnostics Market Size, Share & Trends Analysis Report By Test (Molecular Assays, Non-Molecular Assays), By Product, By Application, By Transplant Area, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

移植診斷市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球移植診斷市場規模將達到97.4億美元，2024年至2030年複合年成長率為7.3%。由於患有經常導致器官衰竭的慢性疾病的患者數量不斷增加，對移植手術的需求正在迅速增加。此外，幹細胞療法和個人化醫療的日益普及正在影響移植診斷的需求。

與器官移植相關的風險和複雜性需要改進和先進的診斷工具。由於對高通量診斷工具的需求不斷增加，次世代定序（NGS）技術正迅速取代傳統的診斷方法，例如用於人類白血球抗原（HLA）分型的血清學方法。

市場成長預計將受到世界某些地區報銷爭議和道德問題等因素的限制。此外，使用聚合酵素鏈鎖反應(PCR) 和 NGS 儀器進行 HLA 匹配的高成本正在影響新興國家移植診斷市場的成長。

移植診斷市場報告亮點

  • 預計從 2024 年到 2030 年，基於序列的打字領域將顯著成長。 NGS 的高採用率是該細分市場成長的主要驅動力。
  • 由於其成熟的研究基礎設施、不斷成長的醫療支出、先進診斷技術的廣泛採用以及研發活動的活性化，預計北美將在 2023 年佔據最大的收益佔有率，並在整個預測期內保持主導地位。
  • 由於研究機會、醫療保健支出、醫療旅遊業和器官捐贈意識的不斷擴大，亞太地區預計將在預測期內顯著成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章移植診斷市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 移植診斷市場分析工具
    • 波特的分析
    • PESTEL分析

第4章移植診斷市場：測試估計和趨勢分析

  • 細分儀表板
  • 移植診斷市場：測試分析（2023/2030）
  • 分子測定
  • 基於定序的分子測定
  • 非分子測定

第5章 移植診斷市場：產品估算與趨勢分析

  • 細分儀表板
  • 移植診斷市場：產品分析（2023/2030）
  • 試劑/耗材
  • 裝置
  • 軟體和服務

第6章 移植診斷市場：使用量估算與趨勢分析

  • 細分儀表板
  • 移植診斷市場：應用分析（2023/2030）
  • 診斷用途
    • 傳染病檢查
    • 組織相容性試驗
    • 血液分析
  • 研究用途

第7章 移植診斷市場：移植部位估算及趨勢分析

  • 細分儀表板
  • 移植診斷市場：移植部位分析（2023/2030）
  • 固態器官移植
  • 幹細胞移植
  • 軟組織移植
  • 骨髓移植

第8章移植診斷市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 移植診斷市場：最終用途分析（2023/2030）
  • 醫院/移植中心
  • 研究/學術機構
  • 獨立參考實驗室

第9章移植診斷市場：區域估計與趨勢分析

  • 移植診斷市場佔有率：依地區分類（2023/2030）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • F. Hoffmann La-Roche Ltd
    • Abbott
    • QIAGEN
    • Bruker
    • BD（Becton, Dickinson and Company）
    • Werfen（Immucor, Inc.）
    • Bio-Rad Laboratories, Inc.
    • Omixon Inc.
簡介目錄
Product Code: 978-1-68038-970-8

Transplant Diagnostics Market Growth & Trends:

The global transplant diagnostics market size is expected to reach USD 9.74 billion by 2030, registering a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increasing number of patients suffering from chronic diseases frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, the adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.

Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to the growing demand for high-throughput diagnostic tools with enhanced accuracy.

Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, the high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.

Transplant Diagnostics Market Report Highlights:

  • The sequencing-based typing segment is anticipated to witness significant growth from 2024 to 2030. High adoption of NGS is a major factor driving segment growth
  • North America captured the largest revenue share in 2023 and is expected to maintain its dominance throughout the forecast period due to well-established research infrastructure, increasing healthcare expenditure, high adoption of advanced diagnostic techniques, and growing R&D activities
  • Asia Pacific is expected to witness significant growth during the forecast period owing to expanding research opportunities, healthcare expenditure, the medical tourism industry, and awareness regarding organ donation

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Transplant Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Transplant Diagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Transplant Diagnostics Market: Test Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Transplant Diagnostics: Test Outlook Analysis, USD Million, 2023 & 2030
  • 4.3. Molecular Assays
    • 4.3.1. PCR-based Molecular Assays
      • 4.3.1.1. PCR-based Molecular Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Real-Time PCR
      • 4.3.2.1. Real-Time PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Sequence-based Primer-PCR
      • 4.3.3.1. Sequence-based Primer-PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Sequence-specific Oligonucleotide-PCR
      • 4.3.4.1. Sequence-specific Oligonucleotide-PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Other PCR-based Molecular Assays
      • 4.3.5.1. Other PCR-based Molecular Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Sequencing-based Molecular Assays
    • 4.4.1. Sanger Sequencing
      • 4.4.1.1. Sanger Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Next Generation Sequencing
      • 4.4.2.1. Next Generation Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Other Sequencing-based Molecular Assays
      • 4.4.3.1. Other Sequencing-based Molecular Assays Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Non-molecular Assays
    • 4.5.1. Serological Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1. Serological Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Mixed Lymphocyte Culture Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.2.1. Mixed Lymphocyte Culture Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transplant Diagnostics Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Transplant Diagnostics Market: Product Analysis, USD Million, 2023 & 2030
  • 5.3. Reagents & Consumables
    • 5.3.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Instruments
    • 5.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Software and Services
    • 5.5.1. Software and Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transplant Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Transplant Diagnostics Market: Application Analysis, USD Million, 2023 & 2030
  • 6.3. Diagnostics Application
    • 6.3.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Infectious Disease Testing
      • 6.3.2.1. Infectious Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Histocompatibility Testing
      • 6.3.3.1. Histocompatibility Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Blood Profiling
      • 6.3.4.1. Blood Profiling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Research Application
    • 6.4.1. Research Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Transplant Diagnostics Market: Transplant Area Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Transplant Diagnostics Market: Transplant Area Analysis, USD Million, 2023 & 2030
  • 7.3. Solid Organ Transplantation
    • 7.3.1. Kidney Transplantation
      • 7.3.1.1. Kidney Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. Liver Transplantation
      • 7.3.2.1. Liver Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Heart Transplantation
      • 7.3.3.1. Heart Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Lungs Transplantation
      • 7.3.4.1. Lungs Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Pancreas Transplantation
      • 7.3.5.1. Pancreas Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Other Organs Transplantation
      • 7.3.6.1. Other Organs Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Stem Cell Transplantation
    • 7.4.1. Stem Cell Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Soft Tissue Transplantation
    • 7.5.1. Soft Tissue Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Bone Marrow Transplantation
    • 7.6.1. Bone Marrow Transplantation Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Transplant Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Transplant Diagnostics Market: End Use Analysis, USD Million, 2023 & 2030
  • 8.3. Hospitals and Transplant Centers
    • 8.3.1. Hospitals and Transplant Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Research and Academic Institutes
    • 8.4.1. Research and Academic Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Independent Reference Laboratories
    • 8.5.1. Independent Reference Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Transplant Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. Transplant Diagnostics Market Share, By Region, 2023 & 2030, USD Million
  • 9.2. North America
    • 9.2.1. North America Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. U.S. Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3. Canada
      • 9.2.3.1. Canada Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Mexico Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. U.K.
      • 9.3.2.1. U.K. Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Germany Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4. France
      • 9.3.4.1. France Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5. Italy
      • 9.3.5.1. Italy Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6. Spain
      • 9.3.6.1. Spain Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7. Denmark
      • 9.3.7.1. Denmark Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.8. Sweden
      • 9.3.8.1. Sweden Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.9. Norway
      • 9.3.9.1. Norway Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Japan Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. China
      • 9.4.3.1. China Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. India
      • 9.4.4.1. India Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Australia
      • 9.4.5.1. Australia Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. South Korea Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Thailand Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Brazil Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Argentina Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. South Africa Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Saudi Arabia Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. UAE
      • 9.6.4.1. UAE Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Kuwait Transplant Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Company Heat Map Analysis
  • 10.4. Company Profiles
    • 10.4.1. Thermo Fisher Scientific, Inc.
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Recent Developments/ Strategic Initiatives
    • 10.4.2. Illumina, Inc.
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Recent Developments/ Strategic Initiatives
    • 10.4.3. F. Hoffmann La-Roche Ltd
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Recent Developments/ Strategic Initiatives
    • 10.4.4. Abbott
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Recent Developments/ Strategic Initiatives
    • 10.4.5. QIAGEN
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Recent Developments/ Strategic Initiatives
    • 10.4.6. Bruker
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Recent Developments/ Strategic Initiatives
    • 10.4.7. BD (Becton, Dickinson and Company)
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Recent Developments/ Strategic Initiatives
    • 10.4.8. Werfen (Immucor, Inc.)
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Recent Developments/ Strategic Initiatives
    • 10.4.9. Bio-Rad Laboratories, Inc.
      • 10.4.9.1. Participant's Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Recent Developments/ Strategic Initiatives
    • 10.4.10. Omixon Inc.
      • 10.4.10.1. Participant's Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Recent Developments/ Strategic Initiatives